Granulocyte-macrophage colony stimulating factor targets lung stem cell niches to accelerate alveolar repair after virus-induced lung injury

Influenza virus pneumonia can cause severe damage to lung tissue, leading to respiratory failure. Rapid and coordinated epithelial tissue repair is essential for restoring gas exchange. Researchers have now identified granulocyte-macrophage colony-stimulating factor (GM-CSF) as a growth factor produced by distal epithelial progenitor cell populations, such as alveolar epithelial type II cells (AECII) and bronchioalveolar stem cells (BASCs), in response to viral lung injury.

Through various experimental models and systems, the researchers found that GM-CSF directly promotes the expansion and alveolarization of these progenitor cells. This occurs by suppressing activation of the AMP-activated protein kinase and enabling mTORC1 signaling, which drives epithelial progenitor cell proliferation. Administering recombinant GM-CSF during the early stages of infection can enhance the proliferation of AECII and their differentiation into AEC type I, accelerating lung barrier repair.

Overall, these findings reveal GM-CSF as a crucial regulator of lung progenitor cell niches, linking cytokine signaling to metabolic control of tissue regeneration. This discovery highlights the therapeutic potential of GM-CSF in promoting lung repair following acute injury.